(Q54272422)

27 May 2018

title

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer. (English)

1 reference

27 May 2018

author

Josep Castellvi

11

1 reference

27 May 2018

Elisabeth Brambilla

13

object named as

Elisabeth Brambilla

1 reference

27 May 2018

author name string

Eva Pros

1

1 reference

27 May 2018

Sylvie Lantuejoul

2

1 reference

27 May 2018

Lydia Sanchez-Verde

3

1 reference

27 May 2018

Sandra D Castillo

4

1 reference

27 May 2018

Ester Bonastre

5

1 reference

27 May 2018

Ana Suarez-Gauthier

6

1 reference

27 May 2018

Esther Conde

7

1 reference

27 May 2018

Juan C Cigudosa

8

1 reference

27 May 2018

Fernando Lopez-Rios

9

1 reference

27 May 2018

Juan Torres-Lanzas

10

1 reference

27 May 2018

Santiago Ramon y Cajal

12

1 reference

27 May 2018

Montse Sanchez-Cespedes

14

1 reference

27 May 2018

language of work or name

English

0 references

publication date

9 March 2013

1 reference

27 May 2018

International Journal of Cancer

published in

1 reference

27 May 2018

volume

133

1 reference

27 May 2018

page(s)

898-907

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

cites work

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

New driver mutations in non-small-cell lung cancer

21 January 2018

1 reference

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

21 January 2018

1 reference

KIF5B-RET fusions in lung adenocarcinoma.

21 January 2018

1 reference

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

21 January 2018

1 reference

A gene-alteration profile of human lung cancer cell lines.

21 January 2018

1 reference

Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors

21 January 2018

1 reference

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors

21 January 2018

1 reference

Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling

21 January 2018

1 reference

The ErbB receptors and their role in cancer progression.

21 January 2018

1 reference

Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

21 January 2018

1 reference

Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens

21 January 2018

1 reference

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

21 January 2018

1 reference

Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer

21 January 2018

1 reference

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

21 January 2018

1 reference

FGFR1 expression and gene copy numbers in human lung cancer.

21 January 2018

1 reference

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes

21 January 2018

1 reference

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

21 January 2018

1 reference

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

21 January 2018

1 reference

Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung

21 January 2018

1 reference

Amplification of chromosomal segment 4q12 in non-small cell lung cancer

21 January 2018

1 reference

EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations.

21 January 2018

1 reference

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28090

1 reference

27 May 2018

release_z2rpuqavhngytp7xu4eij6e4fm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z2rpuqavhngytp7xu4eij6e4fm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23400671

1 reference

27 May 2018